insights_auto
Why is DNA up 21,39%?
Dive Deeperchevron_right
DNA:NYSE
Ginkgo Bioworks Holdings Inc
14,98 $
arrow_upward
+21,39%(+2,64) 1D
15,27 $
arrow_upward
+1,94% (+0,29)todayPre-market
Closed: 5 հոկ, 16:00:02 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNA...
Open
12,50 $
High
15,48 $
Low
12,48 $
Mkt. cap
963,82 մլն
Avg. vol.
1,77 մլն
Volume
75,18 հզր
52-wk high
17,58 $
52-wk low
5,37 $
EPS
-5,00 $
Beta
1,79
Shares outstanding
55,38 մլն
No. of employees
485
Open
12,50 $
High
15,48 $
Low
12,48 $
Mkt. cap
963,82 մլն
Avg. vol.
1,77 մլն
Volume
75,18 հզր
52-wk high
17,58 $
52-wk low
5,37 $
EPS
-5,00 $
Beta
1,79
Shares outstanding
55,38 մլն
No. of employees
485
News stories
From web sources and news partners
Stock Titan
·
17 ժամ առաջ
Officer Steven P. Coen proposes selling 2,403 Ginkgo Bioworks (NYSE: DNA) shares.
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Employees485
Founded2008
HeadquartersԲոստոն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteginkgo.bio